Medical Dynamics

• Sanofi Starts Tender Offer For Outstanding Chattem Shares (The Wall Street Journal)
• H1N1 Flu Is a False Pandemic, Health Expert Claims (Fox News)
• Novartis Gets Patent For Cancer Drug (Business Standard)
• For the Treatment of Alzheimer’s Disease, Pfizer/Medivation’s Dimebon Will Garner Peak Year Sales of $1.5 Billion (PR Newswire)

Read the rest of this entry »

• France Cuts Swine Flu Vaccine Order from Novartis (Reuters)
• Pfizer Resumes Melanoma Drug Study (The Day)
• AstraZeneca Makes Deal with Generic Challenger (Business Week)
• Novartis plans complete takeover of Alcon (Business Week)

Read the rest of this entry »

• Merck Still Plans To Win Big Cost Savings This Year From Schering-Plough Deal (Health News Daily)

This is copyright protected information, to receive the full article, please click here to sign up and register.

• Strides Arcolab Looking to Expand Pfizer Supply Pact (The Wall Street Journal)
• AstraZeneca settles with Teva over generic Nexium (PharmaTimes)

Read the rest of this entry »

• Genzyme to Contract Out Fill And Finish Responsibilities For Four Drugs to Hospira (Health News Daily)

This is copyright protected information, to receive the full article, please click here to sign up and register.

• FDA cancels Lilly’s Cymbalta Chronic Pain Review (Pharma Times)
• Merck, AstraZeneca Pick START to Test Anticancer Compound (San Antonio Business Journal)

Read the rest of this entry »

FDA’s DTC Survey Tweaked At PhRMA’s Suggestion (Health News Daily)

This is copyright protected information, to receive the full article, please click here to sign up and register.

Bristol-Myers Squibb to Announce Results For the Fourth Quarter and Full Year of 2009 on January 28 (Business Wire)
Zydus Cadila scores Indian first with H1N1 vaccine trial (PharmaTimes)

Read the rest of this entry »